Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/02/23 → 7/02/25 |
Keywords
- clinical trial
- multiple myeloma
- Relapsed or Refractory Multiple Myeloma
- Haematological tumours
Clinical Trial Phase
- Phase I
A PHASE 1B, OPEN-LABEL, MULTICENTER DOSE ESCALATION STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF XmAb24306 IN COMBINATION WITH CEVOSTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
- Spencer, Andrew (Primary Chief Investigator (PCI))
- Malherbe, Maturos (Project Manager)
Project: Research